Gene: FKBPL
Official Full Name: FKBP prolyl isomerase likeprovided by HGNC
Gene Summary: The protein encoded by this gene has similarity to the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. The encoded protein is thought to have a potential role in the induced radioresistance. Also it appears to have some involvement in the control of the cell cycle. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17583 | FKBPL Knockout cell line (HeLa) | Human | FKBPL | 1:3~1:6 | Negative | Online Inquiry |
KO17584 | FKBPL Knockout cell line (HCT 116) | Human | FKBPL | 1:2~1:4 | Negative | Online Inquiry |
KO17585 | FKBPL Knockout cell line (HEK293) | Human | FKBPL | 1:3~1:6 | Negative | Online Inquiry |
KO17586 | FKBPL Knockout cell line (A549) | Human | FKBPL | 1:3~1:4 | Negative | Online Inquiry |
FKBPL Gene Knockout Cell Lines are specialized laboratory models designed to facilitate the study of the FKBPL gene's role in cellular processes and disease mechanisms. Through a targeted gene knockout approach utilizing CRISPR-Cas9 technology, these cell lines exhibit a complete loss of FKBPL expression, enabling researchers to investigate the functional implications of FKBPL deletion in the context of various biological pathways.
The primary function of FKBPL, which encodes a protein known to be involved in cellular stress responses and angiogenesis, is critical for maintaining cellular homeostasis. By utilizing FKBPL Gene Knockout Cell Lines, researchers can explore the intricacies of FKBPL-mediated signaling pathways, shedding light on its role in cancer progression, immune responses, and other pathophysiological processes. This information is invaluable for uncovering potential therapeutic targets and developing novel treatment strategies.
The scientific importance of these cell lines is underscored by their versatility in both research and clinical settings, including the development of precision medicine approaches and therapeutic interventions. Unlike traditional models, FKBPL Gene Knockout Cell Lines provide a simplified system for studying the consequences of gene loss, allowing for accelerated results in experimental studies.
The unique selling points of FKBPL Gene Knockout Cell Lines lie in their specificity and reliability. They are produced with rigorous quality control to ensure consistent knockout efficiency, eliminating the variability often seen in other genetically modified systems. Furthermore, these cell lines are compatible with a wide range of molecular and cellular assays, making them adaptable to diverse research needs.
For researchers and clinicians alike, the ability to dissect the functions of the FKBPL gene in a controlled environment offers significant insights into disease mechanisms and therapeutic development. Our company's expertise in gene editing technology and commitment to providing high-quality biological products ensures that our FKBPL Gene Knockout Cell Lines remain an indispensable tool in advancing biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.